News & Updates

Show Multimedia Only
High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer

High-dose radiotherapy boosts biochemical control in Gleason 9–10 prostate cancer

15 Jan 2022

In patients with clinically localized Gleason 9–10 prostate cancer, dose-escalated radiotherapy confers better biochemical disease-free survival and prostate cancer-specific mortality than conventional doses, a recent study has found.

15 Jan 2022
Long-term statin users at risk of colon cancer

Long-term statin users at risk of colon cancer

13 Jan 2022

Use of statins does not appear to be chemopreventive against colorectal cancer (CRC), and no significant association exists between total cholesterol level and CRC risk, a study has found. In addition, long-term statin use may increase the risk of colon cancer.

13 Jan 2022
Autoimmune hepatitis ups 10-year risk of cancer

Autoimmune hepatitis ups 10-year risk of cancer

12 Jan 2022

Autoimmune hepatitis (AIH), a chronic inflammatory liver disease, appears to increase the 10-year risk of cancer by 1.5-fold relative to age- and sex-matched controls, a study has shown.

12 Jan 2022